Laboratory Compound Overview
Isotroin 20 mg Cipla is a synthetic retinoid compound manufactured by Cipla Pharmaceuticals for dermatological and cellular research applications. This oral retinoid formulation represents a vitamin A derivative extensively studied in various laboratory models investigating skin cell differentiation, sebaceous gland function, and keratinocyte proliferation pathways. Researchers investigating acne pathophysiology, sebum production mechanisms, and retinoid receptor signalling often examine this compound’s effects in controlled experimental settings. Each tablet delivers consistent 20 mg dosing for reproducible research protocols.
Research Applications in Laboratory Studies
Scientific investigations frequently examine isotretinoin’s modulation of sebaceous gland activity through multiple cellular pathways. Research models demonstrate significant effects on sebocyte proliferation, differentiation markers, and lipid synthesis regulation. Laboratory studies investigate the compound’s interaction with retinoic acid receptors (RAR) and retinoid X receptors (RXR), particularly in dermatological cell culture systems. Preclinical research examines isotretinoin’s influence on comedogenesis, inflammatory cytokine expression, and keratinisation processes. Many investigations focus on the compound’s ability to normalise follicular hyperkeratinisation and reduce sebaceous gland size in experimental models. Post-cycle therapy research also evaluates isotretinoin’s potential applications in hormonal recovery protocols, making it valuable for researchers studying endocrine modulation alongside compounds available at Stroid UK Shop. Studies examining isotretinoin research compounds often investigate synergistic effects with selective androgen receptor modulators and research peptides in comprehensive experimental designs.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Isotretinoin |
| Concentration | 20 mg per tablet |
| Manufacturer | Cipla Pharmaceuticals |
| Form | Oral tablets |
| Purity | Pharmaceutical grade |
| Storage | Room temperature, dry environment |
| CAS Number | 4759-48-2 |
| Formula | C₂₀H₂₈O₂ |
Research Compliance Notice
Isotroin 20 mg Cipla is supplied exclusively for in-vitro research and laboratory analysis purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate laboratory safety protocols and maintain proper documentation for all experimental procedures. Storage should occur in controlled laboratory environments with restricted access to authorised research personnel only.
